DPG Mitgliedschaft
This block is broken or missing. You may be missing content or you might need to enable the original module.
Keyword: Genentech
News
02.12.2018
- Genentech, part of Swiss drugs giant Roche, has agreed to buy Jecure Therapeutics, a US biotech focused on discovering novel treatments for non-alcoholic steatohepatitis (NASH) and...
News
29.10.2018
- The US Food and Drug Administration (FDA) has approved a new drug produced by Genentech to treat acute uncomplicated influenza (flu) in patients 12 years of age and older who have...
News
04.09.2018
- German biopharma Affimed has agreed a strategic collaboration with Genentech, part of Swiss drug giant Roche, to develop immunotherapies for multiple cancers. Affimed will apply...
News
24.11.2017
- In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...
News
16.06.2017
- US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...
News
12.01.2017
- More than 350 companies headquartered or with operations in the US, including such diverse enterprises as Monsanto, Genentech, Unilever, L’Oreal USA and the Merck Family Fund...
News
06.10.2016
- US biotechnology group Genentech has agreed with Hanmi Pharmaceutical to buy the exclusive global rights to the South Korean company’s experimental cancer drug HM95573. The...
Plant Construction & Process Technology
12.09.2016
- The International Society for Pharmaceutical Engineering (ISPE) recognized 2016 category winners Baxter BioPharma Solutions and Janssen Vaccines for their exceptional leadership in...
Ehrenamtliches Engagement
This block is broken or missing. You may be missing content or you might need to enable the original module.
